SGEF expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.029600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.408000E-01
Normal-vs-Stage2
7.661200E-01
Normal-vs-Stage3
4.548600E-01
Normal-vs-Stage4
6.996200E-01
Stage1-vs-Stage2
4.815000E-01
Stage1-vs-Stage3
1.128160E-01
Stage1-vs-Stage4
8.526200E-01
Stage2-vs-Stage3
3.95109999999921E-05
Stage2-vs-Stage4
7.555800E-01
Stage3-vs-Stage4
4.430000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.970200E-01
Normal-vs-AfricanAmerican
3.872000E-01
Normal-vs-Asian
8.537800E-01
Caucasian-vs-AfricanAmerican
8.326800E-01
Caucasian-vs-Asian
3.242400E-01
AfricanAmerican-vs-Asian
2.346600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.737800E-01
Normal-vs-Female
7.201800E-01
Male-vs-Female
7.525600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.215400E-01
Normal-vs-Age(41-60Yrs)
5.701400E-01
Normal-vs-Age(61-80Yrs)
7.048800E-01
Normal-vs-Age(81-100Yrs)
6.463400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.019600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.855400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.298600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.032600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.809840E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.856230E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.506400E-01
Normal-vs-Daily Drinker
9.824600E-01
Normal-vs-Weekly Drinker
6.869400E-01
Normal-vs-Occasional Drinker
8.049800E-01
Normal-vs-Social Drinker
5.433000E-01
Non Drinker-vs-Daily Drinker
9.107000E-01
Non Drinker-vs-Weekly Drinker
4.976800E-01
Non Drinker-vs-Occasional Drinker
5.966000E-01
Non Drinker-vs-Social Drinker
2.092600E-01
Daily Drinker-vs-Weekly Drinker
3.830000E-01
Daily Drinker-vs-Occasional Drinker
5.589600E-01
Daily Drinker-vs-Social Drinker
1.890770E-01
Weekly Drinker-vs-Occasional Drinker
8.778200E-01
Weekly Drinker-vs-Social Drinker
3.789200E-01
Occasional Drinker-vs-Social Drinker
5.541200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.450200E-01
Normal-vs-Grade 2
4.191000E-01
Normal-vs-Grade 3
3.170000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.253800E-01
Grade 1-vs-Grade 3
4.972100E-02
Grade 1-vs-Grade 4
4.450200E-01
Grade 2-vs-Grade 3
3.945700E-02
Grade 2-vs-Grade 4
4.191000E-01
Grade 3-vs-Grade 4
3.170000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.503400E-01
Normal-vs-NonDiabetic
7.290400E-01
Diabetic-vs-NonDiabetic
6.734600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.078000E-01
Normal-vs-NoPancreatitis
7.719400E-01
Pancreatitis-vs-NoPancreatitis
6.289400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.231400E-01
Normal-vs-N1
7.675800E-01
N0-vs-N1
2.818000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.591800E-01
Normal-vs-TP53-NonMutant
4.389200E-01
TP53-Mutant-vs-TP53-NonMutant
5.437600E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
